Given its role in cancer metabolism, LPL represents a promising therapeutic target. Inhibiting LPL activity could starve cancer cells of essential lipids, thereby hindering their growth and survival. Several small molecule inhibitors and antibodies targeting LPL are currently being investigated in preclinical studies. However, more research is needed to determine the efficacy and safety of these potential treatments.
